Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Change in Intangibles (2023 - 2025)

Historic Change in Intangibles for Genmab A (GMAB) over the last 3 years, with Q1 2025 value amounting to -$18.0 million.

  • Genmab A's Change in Intangibles changed N/A to -$18.0 million in Q1 2025 from the same period last year, while for Dec 2025 it was -$18.0 million, marking a year-over-year change of. This contributed to the annual value of -$18.0 million for FY2025, which is 588.24% down from last year.
  • Genmab A's Change in Intangibles amounted to -$18.0 million in Q1 2025.
  • Genmab A's Change in Intangibles' 5-year high stood at -$1.0 million during Q4 2023, with a 5-year trough of -$18.0 million in Q1 2025.
  • Moreover, its 3-year median value for Change in Intangibles was -$9.5 million (2024), whereas its average is -$9.5 million.
  • Examining YoY changes over the last 5 years, Genmab A's Change in Intangibles showed a top increase of 160000.0% in 2024 and a maximum decrease of 160000.0% in 2024.
  • Quarter analysis of 3 years shows Genmab A's Change in Intangibles stood at -$1.0 million in 2023, then plummeted by 1600.0% to -$17.0 million in 2024, then decreased by 5.88% to -$18.0 million in 2025.
  • Its Change in Intangibles was -$18.0 million in Q1 2025, compared to -$17.0 million in Q4 2024 and -$2.0 million in Q3 2024.